Skip to main content
Clinical Trials/NCT04365010
NCT04365010
Unknown
Phase 4

Effects of Low-chlorine Vs High-chlorine Crystalloid Solutions in Septic Shock Adults

Southeast University, China0 sites100 target enrollmentMay 2020

Overview

Phase
Phase 4
Intervention
Sodium Bicarbonate Ringer's Injection
Conditions
Septic Shock
Sponsor
Southeast University, China
Enrollment
100
Primary Endpoint
the composite of death and new receipt of renal-replacement therapy MAKE30
Last Updated
6 years ago

Overview

Brief Summary

Fluid resuscitation is an important treatment in septic shock patients, however whether crystalloid composition affects septic shock patients outcomes remains unclear. According to previous studies, low-chlorine crystalloids could significantly reduce the incidence of kidney injury and 30-day mortality compared with high-chlorine crystalloids in critically ill adults. Therefore, we hypothesized that the use of low-chlorine crystalloids would result in a lower incidence of major adverse kidney events within 30 days (MAKE 30: overall incidence of death, new renal-replacement therapy, and persistent renal dysfunction) than high-chlorine crystalloids in septic shock adults.

Registry
clinicaltrials.gov
Start Date
May 2020
End Date
December 2021
Last Updated
6 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Southeast University, China
Responsible Party
Principal Investigator
Principal Investigator

Jianfeng Xie

Ph.D

Southeast University, China

Eligibility Criteria

Inclusion Criteria

  • 18 years old \<age ≤ 85 years old;
  • Diagnosis of septic shock within 24 hours (sepsis 3.0);
  • Needing fluid resuscitation judged by clinicians;
  • The patient or the patient's legally acceptable representative signs the informed consent (signs within 24h of enrollment)

Exclusion Criteria

  • Pregnant or lactating period;
  • Renal replacement therapy has been received or expected to receive within 6 hours;
  • Those who were previously enrolled in the study;
  • Estimated death within 24 hours;
  • Other situations that not suitable for enrollment judged by researchers.

Arms & Interventions

Sodium Bicarbonate Ringer's Injection

1. administration route and dosage:Intravenous infusion, 500\~1000 ml/time. The dosage can be increased or decreased according to the age, weight and symptoms. 2. rate: according to the the routine rate of fluid resuscitation of septic shock in the ICUs of Zhongda Hospital, School of Medicine, Southeast University.

Intervention: Sodium Bicarbonate Ringer's Injection

0.9% Sodium Chloride Injection

1. administration route and dosage:Intravenous infusion, 500\~1000 ml/time. The dosage can be increased or decreased according to the age, weight and symptoms. 2. rate: according to the the routine rate of fluid resuscitation of septic shock in the ICUs of Zhongda Hospital, School of Medicine, Southeast University.

Intervention: 0.9% Sodium Chloride Injection

Outcomes

Primary Outcomes

the composite of death and new receipt of renal-replacement therapy MAKE30

Time Frame: up to 30 days

overall incidence of death, new renal-replacement therapy, and persistent renal dysfunction within 30 days

Similar Trials